This compound is a pharmaceutical raw material used as an oral anti-diabetic DPP-4 inhibitor. It is a small-molecule active pharmaceutical ingredient with a complex structure containing aromatic rings and polar functional groups, suitable for use in research and pharmaceutical manufacturing.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1108732-05-3
(S)-Alogliptin Benzoate Salt
active pharmaceutical ingredient
Entrectinib
active pharmaceutical ingredient
N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)(2,2,2-trifluoroacetyl)amino]Benzamide
active pharmaceutical ingredient
Roxatidine Hemioxalate
pharmaceutical intermediate for stomach medicine
Proinsulin C-Peptide (55-89) human
pharmaceutical raw material
2-[[6-[(3R)-3-aminopiperidin-1-yl]-2,4-dioxo-3-(trideuteriomethyl)pyrimidin-1-yl]methyl]benzonitrile
Pharmaceutical intermediate for alogliptin synthesis
Alogliptin (13CD3)
stable isotope labeled active pharmaceutical ingredient
Alogliptin
active pharmaceutical ingredient
2-[[6-[(3S)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile
ZSBOMTDTBDDKMP-HNNXBMFYSA-N
CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@@H](C3)N